Literature DB >> 12632512

Inhibitive effect of cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism.

Yu-Kan Liu1, Wei Shen.   

Abstract

AIM: To investigate the inhibitive effect and its possible mechanism of Cordyceps Sinensis (CS) on CCl(4)-plus ethanol-induced hepatic fibrogenesis in experimental rats.
METHODS: Rats were randomly allocated into a normal control group, a model control group and a CS group. The latter two groups were administered with CCl(4) and ethanol solution at the beginning of the experiment to induce hepatic fibrosis. The CS group was also treated with CS 10 days after the beginning of CCl(4) and ethanol administration. All control groups were given corresponding placebo at the same time. At the end of the 9th week, rats in each group were humanely sacrificed. Blood and tissue specimens were taken. Biochemical, radioimmunological, immunohistochemical and molecular biological examinations were used to determine the level change of ALT, AST, HA, LN content in serum and TGFbeta(1), PDGF, collagen I and III expression in tissue at either protein or mRNA level or both of them.
RESULTS: As compared with the model control group, serum ALT, AST, HA, and LN content levels were markedly dropped in CS group (86.0+/-34.4 vs 224.3+/-178.9, 146.7+/-60.2 vs 272.6+/-130.1, 202.0+/-79.3 vs 316.5+/-94.1 and 50.4+/-3.0 vs 59.7+/-9.8, respectively, P<0.05). Tissue expression of TGFbeta(1) and its mRNA, collagen I mRNA were also markedly decreased (0.2+/-0.14 vs 1.73+/-1.40, 1.68+/-0.47 vs 3.17+/-1.17, 1.10+/-0.84 vs 2.64+/-1.40, respectively, P<0.05). More dramatical drop could be seen in PDGF expression (0.87+/-0.43 vs 1.91+/-0.74, P<0.01). Although there was no statistical significance, it was still strongly suggested that collagen III mRNA expression was also decreased in CS group as compared with model control group (0.36+/-0.27 vs 0.95+/-0.65, P=0.0615). In this experiment, no significant change could be found in PDGF mRNA expression between two groups (0.35+/-0.34 vs 0.70+/-0.46, P>0.05).
CONCLUSION: Cordyceps sinensis could inhibit hepatic fibrogenesis derived from chronic liver injury, retard the development of cirrhosis, and notably ameliorate the liver function. Its possible mechanism involves inhibiting TGFbeta(1) expression, and thereby, down regulating PDGF expression, preventing HSC activation and deposition of procollagen I and III.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12632512      PMCID: PMC4621576          DOI: 10.3748/wjg.v9.i3.529

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Antioxidant activity of the extracts from fruiting bodies of cultured Cordyceps sinensis.

Authors:  Y Yamaguchi; S Kagota; K Nakamura; K Shinozuka; M Kunitomo
Journal:  Phytother Res       Date:  2000-12       Impact factor: 5.878

Review 2.  Matrix as a modulator of hepatic fibrogenesis.

Authors:  D Schuppan; M Ruehl; R Somasundaram; E G Hahn
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 3.  Extracellular matrix degradation and the role of hepatic stellate cells.

Authors:  R C Benyon; M J Arthur
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 4.  Preventive strategies in chronic liver disease: part II. Cirrhosis.

Authors:  T R Riley; A M Bhatti
Journal:  Am Fam Physician       Date:  2001-11-15       Impact factor: 3.292

5.  Effects of Cordyceps sinensis on testosterone production in normal mouse Leydig cells.

Authors:  B M Huang; C C Hsu; S J Tsai; C C Sheu; S F Leu
Journal:  Life Sci       Date:  2001-10-19       Impact factor: 5.037

6.  Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.

Authors:  G Fibbi; M Pucci; C Grappone; G Pellegrini; R Salzano; A Casini; S Milani; M Del Rosso
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

Review 7.  Liver fibrosis and altered matrix synthesis.

Authors:  K Neubauer; B Saile; G Ramadori
Journal:  Can J Gastroenterol       Date:  2001-03       Impact factor: 3.522

8.  Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease.

Authors:  Wei-Xing Chen; You-Ming Li; Chao-Hui Yu; Wei-Min Cai; Min Zheng; Feng Chen
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

9.  Protein constituent contributes to the hypotensive and vasorelaxant activities of Cordyceps sinensis.

Authors:  W F Chiou; P C Chang; C J Chou; C F Chen
Journal:  Life Sci       Date:  2000-02-25       Impact factor: 5.037

Review 10.  Roles of TGF-beta in hepatic fibrosis.

Authors:  Axel M Gressner; Ralf Weiskirchen; Katja Breitkopf; Steven Dooley
Journal:  Front Biosci       Date:  2002-04-01
View more
  13 in total

1.  Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats.

Authors:  Yan-Jun Luo; Jie-Ping Yu; Zhao-Hong Shi; Li Wang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

2.  Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo.

Authors:  Guang-Feng Shi; Qian Li
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis.

Authors:  Yu-Tong He; Dian-Wu Liu; Li-Yu Ding; Qing Li; Yong-Hong Xiao
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

4.  Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis.

Authors:  Qing-He Nie; Guo-Rong Duan; Xin-Dong Luo; Yu-Mei Xie; Hong Luo; Yong-Xing Zhou; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

5.  Functional hepatic flow in patients with liver cirrhosis.

Authors:  Zheng Pan; Xing-Jiang Wu; Jie-Shou Li; Fang-Nan Liu; Wei-Su Li; Jian-Ming Han
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

Review 6.  A Systematic Review of the Mysterious Caterpillar Fungus Ophiocordyceps sinensis in Dong-ChongXiaCao ( Dōng Chóng Xià Cǎo) and Related Bioactive Ingredients.

Authors:  Hui-Chen Lo; Chienyan Hsieh; Fang-Yi Lin; Tai-Hao Hsu
Journal:  J Tradit Complement Med       Date:  2013-01

Review 7.  Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine.

Authors:  Kuo-Hsiung Lee; Susan L Morris-Natschke; Xiaoming Yang; Rong Huang; Ting Zhou; Shou-Fang Wu; Qian Shi; Hideji Itokawa
Journal:  J Tradit Complement Med       Date:  2012-04

8.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

9.  Hirsutella sinensis mycelium attenuates bleomycin-induced pulmonary inflammation and fibrosis in vivo.

Authors:  Tsung-Teng Huang; Hsin-Chih Lai; Yun-Fei Ko; David M Ojcius; Ying-Wei Lan; Jan Martel; John D Young; Kowit-Yu Chong
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

Review 10.  Review of Naturopathy of Medical Mushroom, Ophiocordyceps Sinensis, in Sexual Dysfunction.

Authors:  Kanitta Jiraungkoorskul; Wannee Jiraungkoorskul
Journal:  Pharmacogn Rev       Date:  2016 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.